Thailand - Delayed Quote THB

Mega Lifesciences Public Company Limited (MEGA.BK)

40.25 0.00 (0.00%)
At close: May 17 at 4:39 PM GMT+7
Loading Chart for MEGA.BK
DELL
  • Previous Close 40.25
  • Open 40.25
  • Bid 40.25 x --
  • Ask 40.50 x --
  • Day's Range 40.00 - 40.50
  • 52 Week Range 34.75 - 46.75
  • Volume 1,312,789
  • Avg. Volume 866,077
  • Market Cap (intraday) 35.093B
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) 17.35
  • EPS (TTM) 2.32
  • Earnings Date Aug 9, 2024 - Aug 13, 2024
  • Forward Dividend & Yield 1.60 (3.98%)
  • Ex-Dividend Date Mar 6, 2024
  • 1y Target Est 48.19

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids', men's, and women's care products. The company also offers prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardiovascular system, dermatology, diabetes, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology. In addition, it provides logistical and marketing services for the sale of goods manufactured by third parties, as well as involved in the software design, development, and other services business. The company was founded in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited operates as a subsidiary of Unistretch Limited.

www.megawecare.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MEGA.BK

Performance Overview: MEGA.BK

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MEGA.BK
1.92%
MSCI WORLD
9.57%

1-Year Return

MEGA.BK
10.75%
MSCI WORLD
23.91%

3-Year Return

MEGA.BK
25.70%
MSCI WORLD
0.00%

5-Year Return

MEGA.BK
39.08%
MSCI WORLD
63.33%

Compare To: MEGA.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEGA.BK

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    35.09B

  • Enterprise Value

    32.11B

  • Trailing P/E

    17.35

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.24

  • Price/Book (mrq)

    3.53

  • Enterprise Value/Revenue

    2.05

  • Enterprise Value/EBITDA

    12.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.83%

  • Return on Assets (ttm)

    13.02%

  • Return on Equity (ttm)

    21.07%

  • Revenue (ttm)

    15.72B

  • Net Income Avi to Common (ttm)

    2.02B

  • Diluted EPS (ttm)

    2.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.32B

  • Total Debt/Equity (mrq)

    3.35%

  • Levered Free Cash Flow (ttm)

    1.75B

Research Analysis: MEGA.BK

Company Insights: MEGA.BK

Research Reports: MEGA.BK

People Also Watch